News and Activities
Hot Off The Press.
Press Releases
Proteocyte and the American Academy of Oral Medicine Announce Multi-Year Corporate Affiliate Program Agreement
Toronto, ON; January 2, 2024 - Proteocyte AI is pleased to announce a new 2-year Corporate Affiliate Program agreement with the American Academy of Oral Medicine (AAOM). This corporate affiliate program agreement further reinforces Proteocyte’s dedication to producing a range of technological...
Proteocyte Welcomes Key Advisor Mark Smithyes as Strategic Advisor
Toronto, ON; November 3, 2023 - Proteocyte AI is pleased to announce that Mark Smithyes has joined the organization as a strategic advisor. Mark will play a key role in helping Proteocyte to raise additional capital as the company approaches several key milestones for broader commercialization in...
Proteocyte Receives CLIA Certificate of Accreditation
Toronto, ON; September 25, 2023 - Proteocyte AI is pleased to announce it has been awarded the Clinical Laboratory Improvement Amendments (CLIA) Certificate of Accreditation (CoA), effective August 28th, 2023. The CLIA CoA follows the previously awarded Certificate of Registration, which permitted...
Proteocyte Welcomes Key Advisor Ed Gudaitis as Commercial Launch Gathers Momentum
Toronto, ON; July 19, 2023 - Proteocyte AI is pleased to announce the the addition of Edward Gudaitis as a Business Advisor. Ed is an experienced life sciences and pharmaceutical leader with over 28 years of senior leadership experience across multiple stages of pharmaceutical commercialization...